ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
NEW ORLEANS , Sept. 9, 2022 |PRNewswire| -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 31, 2022 to file lead plaintiff applications in a securities class action lawsuit against Abbott Laboratories (NYSE: ABT ), if they purchased the Company''s shares between February 19, 2021 to June 8, 2022 , inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of Illinois . Get Help Abbott investors should visit us at https:||claimsfiler.com|cases|nyse-abt-1| or call toll-free (844) 367-9658. Lawyers at Kahn Swick Foti, LLC are available to discuss your legal options. About the Lawsuit Abbott and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On … Full story available on Benzinga.com
ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
NEW ORLEANS , Sept. 9, 2022 |PRNewswire| -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 31, 2022 to file lead plaintiff applications in a securities class action lawsuit against Abbott Laboratories (NYSE: ABT ), if they purchased the Company''s shares between February 19, 2021 to June 8, 2022 , inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of Illinois . Get Help Abbott investors should visit us at https:||claimsfiler.com|cases|nyse-abt-1| or call toll-free (844) 367-9658. Lawyers at Kahn Swick Foti, LLC are available to discuss your legal options. About the Lawsuit Abbott and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On … Full story available on Benzinga.com